Cite
XRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodkin Disease: A report from the Childhood Cancer Survivor Study
MLA
Mertens, Ann C., et al. “XRCC1 and Glutathione-S-Transferase Gene Polymorphisms and Susceptibility to Radiotherapy-Related Malignancies in Survivors of Hodkin Disease: A Report from the Childhood Cancer Survivor Study.” Cancer, vol. 101, no. 6, Sept. 2004, p. 1463. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.122515628&authtype=sso&custid=ns315887.
APA
Mertens, A. C., Mitby, P. A., Radloff, G., Jones, I. M., Perentesis, J., Kiffmeyer, W. R., Neglia, J. P., Meadows, A., Potter, J. D., Friedman, D., Yasui, Y., Robison, L. L., & Davies, S. M. (2004, September 15). XRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodkin Disease: A report from the Childhood Cancer Survivor Study. Cancer, 101(6), 1463.
Chicago
Mertens, Ann C., Pauline A. Mitby, Gretchen Radloff, Irene M. Jones, John Perentesis, William R. Kiffmeyer, Joseph P. Neglia, et al. 2004. “XRCC1 and Glutathione-S-Transferase Gene Polymorphisms and Susceptibility to Radiotherapy-Related Malignancies in Survivors of Hodkin Disease: A Report from the Childhood Cancer Survivor Study.” Cancer, September 15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.122515628&authtype=sso&custid=ns315887.